SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 42.35
-0.65 (-1.51%)
Apr 2, 2026, 11:24 AM CET
SKAN Group AG Revenue
In the year 2025, SKAN Group AG had annual revenue of 333.34M CHF, down -7.74%. SKAN Group AG had revenue of 198.77M in the half year ending December 31, 2025, with 10.25% growth.
Revenue
333.34M
Revenue Growth
-7.74%
P/S Ratio
2.90
Revenue / Employee
202.39K
Employees
1,504
Market Cap
966.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 333.34M | -27.96M | -7.74% |
| Dec 31, 2024 | 361.30M | 41.28M | 12.90% |
| Dec 31, 2023 | 320.02M | 43.07M | 15.55% |
| Dec 31, 2022 | 276.96M | 42.69M | 18.22% |
| Dec 31, 2021 | 234.27M | 42.58M | 22.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Aevis Victoria | 955.96M |
| PolyPeptide Group AG | 362.47M |
| Medartis Holding AG | 269.26M |
| Basilea Pharmaceutica AG | 232.38M |